Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Shares Outstanding (2021 - 2025)

Kiniksa Pharmaceuticals International's Shares Outstanding history spans 5 years, with the latest figure at $16.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.0% year-over-year to $16.1 million; the TTM value through Dec 2025 reached $16.1 million, changed 0.0%, while the annual FY2025 figure was $16.1 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $45.7 million in Q4 2025 per KNSA's latest filing, up from $44.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $74.0 million in Q2 2025 to a low of $50000.0 in Q2 2024.
  • Average Shares Outstanding over 5 years is $64.3 million, with a median of $69.6 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: tumbled 99.93% in 2024, then surged 147964.73% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $69.1 million in 2021, then rose by 0.92% to $69.7 million in 2022, then grew by 1.09% to $70.5 million in 2023, then tumbled by 77.21% to $16.1 million in 2024, then changed by 0.0% to $16.1 million in 2025.
  • Per Business Quant, the three most recent readings for KNSA's Shares Outstanding are $16.1 million (Q4 2025), $12.8 million (Q3 2025), and $74.0 million (Q2 2025).